ABOUT TRADECRAFT
Tradecraft Clinical Research is a life sciences consulting firm providing expertise in the Statistical Programming and Biostatistics disciplines for life sciences organizations. We partner with our clients to provide statistical analysis services for product development, regulatory submissions, and to assist in expediting the drug approval process.
Our mission is to deliver high-quality, on-time deliverables in support of our clients' goals.
LEADERSHIP TEAM
Mike Willis
CEO
Brittaney Ortland
Vice President,
Project Management
John Ilgenfritz
Vice President, Biostatistics
As our CEO, Mike's focus has always been on keeping us accountable to our clients. His is a process-oriented leadership style that places ethics as our number one priority and follows it up with 22 years of experience in pharmaceuticals, a phenomenal set of technical skills, and a commitment to the exchange of ideas. He is also a PharmaVOICE 100 recipient! Contact
Brittaney is our Vice President of Project Management. Her collaborative approach, attention to detail, and understanding of our clients’ goals help us maintain speed and transparency across our portfolio of projects. Her adept planning methods and flexible management techniques help us deliver greater value to our clients every day.
With going on 30 years of experience in the field, John’s statistical analysis expertise in the planning, analysis, and interpretation of clinical trials is beyond comparison. He knows the industry and focuses on clients’ needs with pinpoint precision.
J. Kanan Sawyer, Ph.D.
Head of Communications
Kanan helps to keep us targeted on clear communication. She brings more than two decades of experience in communication training and presentation skills to the table and is simultaneously a tenured Associate Professor of Communication at WCU. (Plus, she keeps correcting our grammar!)
Karl Fischer
VP, Product Development & Software Strategy
With a focus on providing value to clients beyond our core Programming and Biostatistics Services, Karl is guiding our software strategy and leading efforts to develop the DataVIEWS clinical data analysis and visualization tool. We want to leverage the evolving open-source programming technology with CDISC data standards. This approach provides analysis results faster and enables visibility and insights into trial data as early and often as possible to aid decisions and improve the success rate and speed of drug development.
Congratulations to CEO, Mike Willis, who was honored for his inclusion in the 2020 PharmaVOICE 100. These awards recognize the most inspiring people in the life-sciences industry and include leaders in research and development, marketing, technology, creativity, strategy, and medicine. They acknowledge individuals who positively impact their peers, their colleagues, their companies, their communities, as well as the industry at large through their actions.